P110α
蛋白质亚单位
磷脂酰肌醇
突变体
点突变
激酶
基因
细胞生长
PI3K/AKT/mTOR通路
突变
细胞生物学
细胞
癌基因
生物
细胞分裂
信号转导
化学
遗传学
细胞周期
作者
Namrata Kalsi,Chandrasekhar Gopalakrishnan,Vidya Rajendran,Rituraj Purohit
标识
DOI:10.1080/07391102.2015.1127774
摘要
Genetic variations in oncogenes can often promote uncontrolled cell proliferation by altering the structure of the encoded protein, thereby altering its function. The PI3KCA oncogene that encodes for p110α, the catalytic subunit of phosphatidylinositol 3-kinase (PI3K), is one the most frequently mutated oncogenes in humans. PI3K plays a pivotal role in cell division. PI3K consists of two subunits: the catalytic (p110α) and regulatory (p85α). The regulatory subunit usually controls the catalytic subunit and switches off the enzyme when not required. It is believed that mutations in PI3KCA gene can alter the control of p85α over p110α and can sustain p110α in a prolonged active state. This in turn results in uncontrolled cell division. In this study, we investigate the pathogenic role of two point mutations: E542K and E545K on p110α subunit and how they alter its binding with the regulatory subunit. Molecular interaction and molecular dynamic simulation analysis are performed to study the dynamic behaviour of native and mutant structures at atomic level. Mutant p110α showed less interaction with its regulatory partner p85α than the native did, due to its expanded and rigid structure. Our analysis clearly points out that the structural and functional consequences of the mutations could promote tumour proliferation.
科研通智能强力驱动
Strongly Powered by AbleSci AI